课题基金 / 基金详情

Dissecting the Red Blood Cell Invasion Pathways of the Malaria Parasite Plasmodium knowlesi

Dissecting the Red Blood Cell Invasion Pathways of the Malaria Parasite Plasmodium knowlesi
剖析疟疾寄生虫诺氏疟原虫的红细胞侵袭途径
批准号:
MR/M021157/1
负责人:
Robert Moon
金额:
$138.35万
依托单位国家:
英国
项目类别:
Fellowship
财政年份:
2015
资助国家:
英国
项目状态:
已结题
起止时间:
2015 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Malaria is one of the most important infectious diseases of man with more than half of the world's population living at risk of the disease, and resulting in more than half a million deaths per year. The disease is caused by Plasmodium species, single-celled parasites that can be transferred to humans by the bite of an infected mosquito. Symptoms of the disease result from the parasite destroying red blood cells by first entering them, growing and replicating inside them, before bursting out and invading other red blood cells in a continuous cycle. The parasites produce a range of adhesive proteins enabling them to bind to specific proteins on the surface of red blood cells and establish the process of red blood cell invasion. Because of their crucial role in the invasion process these parasite proteins are important vaccine targets. They also determine how effectively parasites can replicate and so can affect disease severity as well as determining which hosts are susceptible to malaria.In this project I will investigate the role of these proteins during the invasion process using a malaria parasite known as Plasmodium knowlesi. This parasite naturally infects macaque monkeys in South-East Asia, and was recently found to be a significant cause of severe and fatal human infections. In recent work I have developed methods to grow this parasite in culture with human red blood cells for the first time, and established highly efficient techniques to genetically modify the parasite. I will use these techniques to generate parasites in which I have deleted genes encoding the adhesive proteins. This will enable me to determine which are essential for invasion and which can be deleted without any effect on the invasion process. Using similar techniques I will also add fluorescent "tags" to each of the proteins coded by the target genes, so that I can determine where the adhesive proteins are in the cell and where they move during the invasion process. The "tags" will also allow me to identify parasite proteins that interact with the adhesive proteins as well as what they specifically bind to on the host red blood cell surface. I will analyse both the gene deletion and "tagged" parasite lines using cutting edge imaging technologies including electron tomography and super resolution microscopy, which have never before been used to visualise invasion of this parasite species. This will provide critical insight into the mechanism of invasion of all malaria parasites, as well as identifying precisely which parasite proteins and host proteins are required for P. knowlesi to invade human red blood cells. The latter is of particular importance as it may explain how a macaque malaria parasite is able to spread to infect humans and determine the potential for emergence of human-to-human transmission of the parasite.Whilst there is currently no vaccine for malaria, there is great interest and several vaccine candidates under development for the most common and serious cause of malaria P. falciparum. However, vaccine development for the second most common cause of malaria P. vivax, is hampered by the fact that it cannot be grown in the laboratory. This means that testing new vaccines would involve infecting people or non-human primates with P. vivax. The primary vaccine candidate for P. vivax is one of the parasite's adhesive proteins. P. knowlesi is closely related to P. vivax and also uses a similar version of this adhesive protein. By genetically modifying P. knowlesi to replace the gene encoding the adhesive protein with the version from P. vivax, it will be possible to determine whether a vaccine can induce antibodies that kill parasites in culture, before it is necessary to test it in people. Thus I will use the unique biology of P. knowlesi along with the technical advantages of the model to not only study the process of invasion but also generate important tools to expedite the development of vital malaria vaccines.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
The Binding of Plasmodium falciparum Adhesins and Erythrocyte Invasion Proteins to Aldolase Is Enhanced by Phosphorylation.
恶性疟原虫粘附素和红细胞侵袭蛋白与醛糖酶的结合通过磷酸化增强。
DOI: 10.1371/journal.pone.0161850
发表时间: 2016
期刊: PloS one
影响因子: 3.7
作者: [Diaz SA, Martin SR, Howell SA, Grainger M, Moon RW, Green JL, Holder AA]
通讯作者: Holder AA
DOI: 10.1038/s41467-021-23422-3
发表时间: 2021-05-26
期刊: Nature communications
影响因子: 16.6
作者: [Benavente ED, Manko E, Phelan J, Campos M, Nolder D, Fernandez D, Velez-Tobon G, Castaño AT, Dombrowski JG, Marinho CRF, Aguiar ACC, Pereira DB, Sriprawat K, Nosten F, Moon R, Sutherland CJ, Campino S, Clark TG]
通讯作者: Clark TG
Comparative heterochromatin profiling reveals conserved and unique epigenome signatures linked to adaptation and development of malaria parasites
比较异染色质分析揭示了与疟疾寄生虫的适应和发育相关的保守且独特的表观基因组特征
DOI: 10.5451/unibas-ep62678
发表时间: 2018
期刊:
影响因子: --
作者: [Fraschka, Sabine A.]
通讯作者: Fraschka, Sabine A.
Sequential roles for red blood cell binding proteins enable phased commitment to invasion for malaria parasites
红细胞结合蛋白的连续作用使得疟疾寄生虫能够分阶段入侵
DOI: 10.1101/2022.08.09.503398
发表时间: 2022
期刊:
影响因子: --
作者: [Hart M]
通讯作者: Hart M
8
    国内基金
    海外基金
    Red/ET重组BCAS1工程菌的构建及通过MUC2调控缓解仔猪腹泻的机制研究
    • 批准号:
      2026JJ70027
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      王雁灿
    • 依托单位:
    高质子选择性与高质子电导率的薄层复合阳离子交换膜的制备及其在反向电渗析(RED)技术中的应用研究
    • 批准号:
      --
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      30万元
    • 批准年份:
      2022
    • 负责人:
      梅颖
    • 依托单位:
    RED重组酶与内源Ku蛋白在莱茵衣藻核基因同源重组定向改造中的相互作用分析
    • 批准号:
      31870343
    • 项目类别:
      面上项目
    • 资助金额:
      60.0万元
    • 批准年份:
      2018
    • 负责人:
      贾彬
    • 依托单位:
    利用Red/ET DNA重组工程改造蛋白酶体抑制剂syrbactins生物合成途径开发抗肿瘤药物
    • 批准号:
      31670097
    • 项目类别:
      面上项目
    • 资助金额:
      60.0万元
    • 批准年份:
      2016
    • 负责人:
      张友明
    • 依托单位: